Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT00373841
Status
Recruiting
Apply to this trial

Conditions

  • Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic markers of samples to changes in symptoms. The ultimate goal is to predict if or when patients are likely to experience a rapid decline in lung function due to disease progression.

Key Dates

Start date
Oct 31, 2005
Status verified
Sep 2025
Primary completion
Jul 31, 2030
Completion
Jul 31, 2030

Study Design

Enrollment
500 participants (estimated)

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Michelle F MacPhersonPittsburghPennsylvania15213
Michelle F MacPherson, MAT
[email protected]
14126474537
Michelle L Meyers, BSN RN
[email protected]
412-692-2149
Luis Ortiz, MD (SUB_INVESTIGATOR)
Prabhir Ray, PhD (SUB_INVESTIGATOR)
Yingze Zhang, PhD (SUB_INVESTIGATOR)
Kristen Veraldi, M.D. (SUB_INVESTIGATOR)
Daniel J. Kass, M.D. (SUB_INVESTIGATOR)
Michelle F. MacPherson, BS, MAT (SUB_INVESTIGATOR)
Michelle Meyers, BSN, RN (SUB_INVESTIGATOR)
Kevin F Gibson, MD (PRINCIPAL_INVESTIGATOR)
Morgan L Carnahan, BS (SUB_INVESTIGATOR)
Daniel Sullivan, MD (SUB_INVESTIGATOR)
Eleanor Valenzi, MD (SUB_INVESTIGATOR)
Seyed Mehdi Nouraie, MD (SUB_INVESTIGATOR)
Xiaoping Chen, MS (SUB_INVESTIGATOR)
Gillian Goobie, MD PhD (SUB_INVESTIGATOR)
John Sembrat, PhD (SUB_INVESTIGATOR)
Timothy Corcoran, PhD (SUB_INVESTIGATOR)
Xiaoyun Li, MD (SUB_INVESTIGATOR)

Find similar trials in Pittsburgh, PA

By research site
Michelle F MacPherson· Pittsburgh, PA

Related Studies